Treatment paradigms in Parkinson's Disease and Covid-19

Iro Boura*, Lucia Batzu, Espen Dietrichs, Kallol Ray Chaudhuri

*Corresponding author for this work

Research output: Chapter in Book/Report/Conference proceedingChapterpeer-review

1 Citation (Scopus)


People with Parkinson's Disease (PwP) may be at higher risk for complications from the Coronavirus Disease 2019 (Covid-19) due to older age and to the multi-faceted nature of Parkinson's Disease (PD) per se, presenting with a variety of motor and non-motor symptoms. Those on advanced therapies may be particularly vulnerable. Taking the above into consideration, along with the potential multi-systemic impact of Covid-19 on affected patients and the complications of hospitalization, we are providing an evidence-based guidance to ensure a high standard of care for PwP affected by Covid-19 with varying severity of the condition. Adherence to the dopaminergic medication of PwP, without abrupt modifications in dosage and frequency, is of utmost importance, while potential interactions with newly introduced drugs should always be considered. Treating physicians should be cautious to acknowledge and timely address any potential complications, while consultation by a neurologist, preferably with special knowledge on movement disorders, is advised for patients admitted in non-neurological wards. Non-pharmacological approaches, including the patient's mobilization, falls prevention, good sleep hygiene, emotional support, and adequate nutritional and fluid intake, are essential and the role of telemedicine services should be strengthened and encouraged.

Original languageEnglish
Title of host publicationCovid-19 and Parkinsonism
EditorsK Ray Chaudhuri, Mayela Rodríguez-Violante, Angelo Antonini, Iro Boura
Number of pages37
ISBN (Print)9780323991735
Publication statusPublished - Jan 2022

Publication series

NameInternational Review of Neurobiology
ISSN (Print)0074-7742
ISSN (Electronic)2162-5514


  • Covid
  • Hospitalization
  • Management
  • Pandemic
  • Parkinson
  • Treatment


Dive into the research topics of 'Treatment paradigms in Parkinson's Disease and Covid-19'. Together they form a unique fingerprint.

Cite this